Edition:
United States

Insider Trading: Achillion Pharmaceuticals Inc (ACHN.O)

ACHN.O on Nasdaq

3.76USD
24 Mar 2017
Change (% chg)

$-0.03 (-0.79%)
Prev Close
$3.79
Open
$3.80
Day's High
$3.85
Day's Low
$3.75
Volume
1,104,844
Avg. Vol
1,661,030
52-wk High
$10.06
52-wk Low
$3.75

All Insider Trades
Trading Date Name Title Type Shares Traded Price
21 Dec 2016

Fisherman (Jason S)

Director Buy 10,000 $3.96
4 Dec 2016

Fenton (Mary Kay)

Chief Financial Officer Buy 2,500 $4.11
1 Dec 2016

Truitt (Joseph)

Officer Buy 3,500 $4.06
1 Dec 2016

Barrish (Joel C.)

Officer Buy 2,500 $4.06
1 Dec 2016

Manning (Martha E)

General Counsel Buy 2,500 $4.09
1 Dec 2016

Deshpande (Milind S)

Chief Executive Officer Buy 2,500 $4.06
29 Dec 2015

Apelian (David)

Officer Buy 10,000 $3.02
29 Dec 2015

Apelian (David)

Officer Sell 10,000 $10.50
27 Dec 2015

Fenton (Mary Kay)

Chief Financial Officer Sell 43,500 $10.08
27 Dec 2015

Fenton (Mary Kay)

Chief Financial Officer Buy 43,500 $1.05
10 Nov 2015

Vitullo (Nicole)

Director Sell 370 $10.31
10 Nov 2015

Vitullo (Nicole)

Director Sell 49,630 $10.31
9 Nov 2015

Vitullo (Nicole)

Director Sell 177,749 $10.43
9 Nov 2015

Vitullo (Nicole)

Director Sell 1,325 $10.43
8 Nov 2015

Vitullo (Nicole)

Director Sell 2,375 $10.01
8 Nov 2015

Vitullo (Nicole)

Director Sell 318,551 $10.01
24 Sep 2015

Vitullo (Nicole)

Director Sell 69 $8.22
24 Sep 2015

Vitullo (Nicole)

Director Sell 9,241 $8.22
17 Aug 2015

Vitullo (Nicole)

Director Sell 483,521 $0.00
17 Aug 2015

Vitullo (Nicole)

Director Buy 31,431 $0.00
13 Aug 2015

Vitullo (Nicole)

Director Sell 37,843 $7.51
20 May 2015

Vitullo (Nicole)

Director Buy 222,630 $0.00
20 May 2015

Vitullo (Nicole)

Director Sell 1,700,000 $0.00

Institutional Holders

% Shares Owned: 77.47%
# of Holders: 200
Total Shares Held: 105,914,621
3 Mo. Net Change: -8,088,834
# New Positions: 21
# Closed Positions: 46
# Increased Positions: 91
# Reduced Positions: 91
# Net Buyers: 0

Officers & Directors

Name Age Since Current Position

David Scheer

63 2010 Chairman of the Board

Milind Deshpande

59 2013 President, Chief Executive Officer, Director

Mary Fenton

51 2015 Chief Financial Officer, Executive Vice President

Joel Barrish

58 2016 Executive Vice President, Chief Scientific Officer

Martha Manning

61 2016 Executive Vice President, General Counsel, Corporate Secretary

David Apelian

50 2013 Executive Vice President, Chief Medical Officer

Joseph Truitt

51 2014 Executive Vice President, Chief Commercial Officer

Amy Jennings

2016 Senior Vice President - Regulatory Affairs

Michael Kishbauch

67 2013 Director

Frank Verwiel

55 2015 Director

Jason Fisherman

58 2000 Independent Director

Gary Frashier

78 2008 Independent Director

Kurt Graves

48 2012 Independent Director

Robert Van Nostrand

59 2007 Independent Director

Nicole Vitullo

58 2010 Independent Director